In the heterozygous Hb E and heterozygous β-thalassemia groups, two or three α-globin gene deletions result in significant changes in hematocrit, hemoglobin, MCV, MCH, RDW, and Hb E levels. This evidence concerns the gene GSTM1 and thalassemia.